Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
Through a series of experiments supported by the National Institutes of Health, Johns Hopkins Medicine (JHM) researchers say ...
Age-Related Macular Degeneration (AMD) doesn’t get talked about enough in India, and that’s a big problem. One reason is simple: most people think vision loss is just a “normal part of ageing.” If ...
The National Institutes of Health (NIH) researchers have developed a digital replica of crucial eye cells, providing a new tool for studying how the cells organize themselves when they are healthy and ...
After months of workforce reductions and sliding equipment sales, John Deere is reversing course, announcing it will bring 140 employees back to its Waterloo, Iowa, operations as demand ticks higher ...
If you’ve noticed it’s more difficult to focus on objects up close as you age, you’re not alone. Approximately 128 million Americans suffer from a common form of vision loss—and the number is only ...
In retinal disease screenings, artificial intelligence can help deliver diagnoses earlier, giving physicians more time to preserve vision.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results